Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ventyx Biosciences, Inc. - Common Stock
(NQ:
VTYX
)
13.82
+3.77 (+37.56%)
Streaming Delayed Price
Updated: 10:00 AM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ventyx Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Wednesday's pre-market session: top gainers and losers
↗
Today 8:30 EST
Via
Chartmill
Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today
↗
Today 4:22 EST
Via
Stocktwits
Topics
Stocks
Tuesday's after hours session: top gainers and losers
↗
January 06, 2026
Via
Chartmill
Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout
↗
January 06, 2026
A deal for Ventyx could be announced imminently, the Wall Street Journal reported, citing people familiar with the matter.
Via
Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Ventyx Provides Clinical and Corporate Updates
December 02, 2025
From
Ventyx Biosciences, Inc.
Via
GlobeNewswire
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
December 01, 2025
From
Ventyx Biosciences, Inc.
Via
GlobeNewswire
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London
November 17, 2025
From
Ventyx Biosciences, Inc.
Via
GlobeNewswire
Which stocks have an unusual volume on Friday?
↗
October 24, 2025
Volume analysis on 2025-10-24: stocks with an unusual volume in today's session.
Via
Chartmill
Crude Oil Surges 5%; American Airlines Shares Jump After Q3 Results
↗
October 23, 2025
Via
Benzinga
Here are the top movers in Thursday's session.
↗
October 23, 2025
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Most active stocks in Thursday's session
↗
October 23, 2025
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
Via
Chartmill
Ventyx Stock Is Rallying Thursday: What's Driving The Surge?
↗
October 23, 2025
Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for VTX3232.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 23, 2025
Via
Benzinga
Which stocks are moving on Thursday?
↗
October 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
These stocks are gapping in today's session
↗
October 23, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Dow Gains 50 Points; Tesla Shares Slide After Q3 Earnings
↗
October 23, 2025
Via
Benzinga
Topics
Stocks
Wondering what's happening in today's pre-market session?
↗
October 23, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 23, 2025
Via
Benzinga
Why LendingClub Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
↗
October 23, 2025
Via
Benzinga
Ventyx Biosciences Stock: Retail Buzz Spikes After Phase 2 Win In Obesity And Heart Risk Study
↗
October 23, 2025
The Phase 2 trial showed VTX3232 cut key inflammation markers like hsCRP by about 78% and IL-6 to below risk thresholds, reinforcing its anti-inflammatory potential.
Via
Stocktwits
Why Ventyx (VTYX) Shares Soared 86.5% After Hours?
↗
October 23, 2025
Ventyx shares jumped 86.5% in after-hours trading after positive Phase 2 trial results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 22, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Wednesday?
↗
October 22, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
October 22, 2025
From
Ventyx Biosciences, Inc.
Via
GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
October 01, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 11, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
